Pursuant to Regulation 3(5) and 3(6) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Pharmaids Pharmaceuticals has informed that it attached the SDD Compliance Certificate for the Quarter ended June 30, 2022.
The above information is a part of company’s filings submitted to BSE.